Marinus Pharma (MRNS) Tops Q2 EPS by 11c

Marinus Pharma (NASDAQ: MRNS) reported Q2 EPS of ($0.61), $0.11 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $6.08 million versus the consensus estimate of $5.71 million.

For earnings history and earnings-related data on Marinus Pharma (MRNS) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Jersey Mike's Subs (JMKE) PT Raised to $29 at Guggenheim
• RH shares jump after second quarter beat